Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Optimi Health ( (TSE:OPTI) ) has issued an announcement.
Optimi Health has successfully closed its non-brokered private placement, raising a total of $934,000 through the issuance of Units, which include common shares and warrants. The proceeds will be used for general working capital. Additionally, the company has completed a debt settlement with two creditors, retiring $98,501.25 of debt by issuing common shares. This financial maneuvering underscores the company’s strategic efforts to stabilize its financial standing and maintain its growth trajectory in the psychedelics pharmaceutical industry.
More about Optimi Health
Optimi Health Corp. is a GMP-approved, Health Canada licensed psychedelics pharmaceutical manufacturer that specializes in botanical psilocybin and MDMA.
YTD Price Performance: 0.0%
Average Trading Volume: 68,201
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$21.77M
Learn more about OPTI stock on TipRanks’ Stock Analysis page.